Cart
sales@molnova.com
(2S)-2-(Benzoyloxy)butanedioic acid
CAS No. 22138-51-8
(2S)-2-(Benzoyloxy)butanedioic acid( ——— )
Catalog No. M38537 CAS No. 22138-51-8
Benzoyl (S)-(-)-malic acid is a benzoyl malate ester compound that can be found in Medicago sativa.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(2S)-2-(Benzoyloxy)butanedioic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionBenzoyl (S)-(-)-malic acid is a benzoyl malate ester compound that can be found in Medicago sativa.
-
DescriptionBenzoyl (S)-(-)-malic acid is a benzoyl malate ester compound that can be found in Medicago sativa.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number22138-51-8
-
Formula Weight238.195
-
Molecular FormulaC11H10O6
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yoshihara T, et al. Benzoic acid derivatives conjugated with dicarboxylic acids from alfalfa (Medicago sativa)J. Agricultural and Biological Chemistry, 1977, 41(12): 2427-2429.
molnova catalog
related products
-
Halopemide
Halopemide is a potent inhibitor of PLD (IC50 = 220 and 310 nM for human PLD1 and PLD2). Halopemid is an antagonist of dopamine receptors. Halopemid can be used in psychotropic research.
-
Amino-PEG8-amine
Amino-PEG8-amine is a pegylated based PROTAC linker that can be used in the synthesis of PROTACs. It is a conjugate PEG derivative containing two amino (NH2) groups.
-
Syntide 2 (TFA) (108...
Syntide 2 (TFA) is a Ca2+ and CaM dependent protein kinase II (CaMKII) substrate peptide that selectively inhibits the gibberellin (GA) response, leaving composition and slicoic acid regulatory events unaffected.
